tiprankstipranks
Trending News
More News >
Britannia Life Sciences Inc (TSE:BLAB)
:BLAB
Advertisement

Britannia Life Sciences Inc (BLAB) Stock Statistics & Valuation Metrics

Compare
2 Followers

Total Valuation

Britannia Life Sciences Inc has a market cap or net worth of C$10.55M. The enterprise value is C$23.69M.
Market CapC$10.55M
Enterprise ValueC$23.69M

Share Statistics

Britannia Life Sciences Inc has 162,254,330 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding162,254,330
Owned by Insiders
Owned by Institutions

Financial Efficiency

Britannia Life Sciences Inc’s return on equity (ROE) is 1.17 and return on invested capital (ROIC) is -27.58%.
Return on Equity (ROE)1.17
Return on Assets (ROA)0.64
Return on Invested Capital (ROIC)-27.58%
Return on Capital Employed (ROCE)-0.28
Revenue Per Employee10.00T>
Profits Per Employee-10.00T>
Employee Count
Asset Turnover0.03
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Britannia Life Sciences Inc is ―. Britannia Life Sciences Inc’s PEG ratio is ―.
PE Ratio
PS Ratio
PB Ratio
Price to Fair Value1.93
Price to FCF
Price to Operating Cash Flow-4.34
PEG Ratio

Income Statement

In the last 12 months, Britannia Life Sciences Inc had revenue of 369.28K and earned 7.39M in profits. Earnings per share was 0.04.
Revenue369.28K
Gross Profit27.33K
Operating Income-2.25M
Pretax Income-4.56M
Net Income7.39M
EBITDA-4.39M
Earnings Per Share (EPS)0.04

Cash Flow

In the last 12 months, operating cash flow was -2.62M and capital expenditures -283.04K, giving a free cash flow of -2.62M billion.
Operating Cash Flow-2.62M
Free Cash Flow-2.62M
Free Cash Flow per Share-0.02

Dividends & Yields

Britannia Life Sciences Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta-0.72
52-Week Price Change20.00%
50-Day Moving Average0.07
200-Day Moving Average0.07
Relative Strength Index (RSI)38.96
Average Volume (3m)194.94K

Important Dates

Britannia Life Sciences Inc upcoming earnings date is Nov 27, 2025, After Close (Confirmed).
Last Earnings DateAug 29, 2025
Next Earnings DateNov 27, 2025
Ex-Dividend Date

Financial Position

Britannia Life Sciences Inc as a current ratio of 2.72, with Debt / Equity ratio of 29.49%
Current Ratio2.72
Quick Ratio2.72
Debt to Market Cap0.14
Net Debt to EBITDA1.36
Interest Coverage Ratio-21.19

Taxes

In the past 12 months, Britannia Life Sciences Inc has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Britannia Life Sciences Inc EV to EBITDA ratio is -1.41, with an EV/FCF ratio of -2.36.
EV to Sales16.73
EV to EBITDA-1.41
EV to Free Cash Flow-2.36
EV to Operating Cash Flow-2.36

Balance Sheet

Britannia Life Sciences Inc has C$7.85M in cash and marketable securities with C$1.86M in debt, giving a net cash position of -C$5.99M billion.
Cash & Marketable SecuritiesC$7.85M
Total DebtC$1.86M
Net Cash-C$5.99M
Net Cash Per Share-C$0.04
Tangible Book Value Per ShareC$0.04

Margins

Gross margin is 7.40%, with operating margin of -609.28%, and net profit margin of 2001.95%.
Gross Margin7.40%
Operating Margin-609.28%
Pretax Margin-1235.00%
Net Profit Margin2001.95%
EBITDA Margin-1189.96%
EBIT Margin-1206.25%

Analyst Forecast

The average price target for Britannia Life Sciences Inc is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price Target
Price Target Upside
Analyst ConsensusModerate Sell
Analyst Count0
Revenue Growth Forecast-3.93%
EPS Growth Forecast-575.24%

Scores

Smart ScoreN/A
AI Score40
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis